Abstract
Introduction
The community deintensification rates in older people with diabetes are low and hospital admission presents an opportunity for medication review. We audited the inpatient assessment and deintensification rate in people with diabetes and frailty. We also identified factors associated with adverse inpatient outcomes.
Methods
A retrospective review of electronic charts was conducted in all people with diabetes and clinical frailty score ≥6 who were discharged from the medical unit in 2022. Data on demographics, comorbidities and background glucose-lowering medications were collected.
Results
Six-hundred-and-sixty-five people with diabetes and moderate/severe frailty were included in our analysis. For people with no HbA1c in the last six months preceding admission, only 9.0% had it assessed during inpatient. Deintensification rates were 19.1%. Factors that were associated with adverse inpatient outcomes included inpatient hypoglycaemia, non-White ethnicity, and being overtreated (HbA1c
Original language | English |
---|---|
Article number | 100029 |
Journal | Clinical Medicine |
Early online date | 20 Feb 2024 |
DOIs | |
Publication status | E-pub ahead of print - 20 Feb 2024 |
Keywords
- diabetes
- frailty
- quality improvment
- inpatient hypoglycaemia